Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy

Semaille, Caroline; Strat, Yann Le; Chiron, Éliane; Chemlal, K; Valantin, M.A.; Serre, P.; Caté, L; Barbier, C; Jauffret‐Roustide, Marie; Group, Collective the Prevacar

doi:10.2807/1560-7917.es2013.18.28.20524

Cited by 59 publications

(62 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Studies from a variety of settings confirmed that HIV prevalence remains higher among incarcerated populations as compared to analogous non-incarcerated groups [33–36,39] and often co-occurs with other infectious diseases, especially viral hepatitis and tuberculosis [32,34–36,39]. Recent evidence from the United States indicates that voluntary HIV rapid testing within jail and prison settings is feasible and effective [62,63].…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Incarceration of People Living with HIV/AIDS: Implications for Treatment-as-Prevention

2014

View full text Add to dashboard Cite

Contact with the criminal justice system, including incarceration, is a common experience for many people living with HIV/AIDS. Optimism has recently been expressed that correctional facilities could be important locations for Treatment-as-Prevention (TasP)-based initiatives. We review recent findings regarding the effect of incarceration on patterns of HIV transmission, testing, treatment initiation and retention. We found that the prevalence of HIV infection among incarcerated individuals remains higher than analogous non-incarcerated populations. Recent studies have shown that voluntary HIV/AIDS testing is feasible in many correctional facilities, although the number of previously undiagnosed individuals identified has been modest. Studies have implied enhanced linkage to HIV/AIDS treatment and care in jails in the United States was associated with improvements in the HIV cascade of care. However, for many individuals living with HIV/AIDS, exposure to the correctional system remains an important barrier to retention in HIV/AIDS treatment and care. Future research should evaluate structural interventions to address these barriers and facilitate the scale-up of TasP-based efforts among individuals living in correctional settings.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Recent analyses of the prevalence of HIV and related infections in correctional populations have confirmed this pattern [32–36]. Of particular note are the results from an HIV/TB screening program established in six prisons in Zambia [34].…”

Section: Hiv Prevalence/riskmentioning

confidence: 92%

Incarceration of People Living with HIV/AIDS: Implications for Treatment-as-Prevention

2014

View full text Add to dashboard Cite

show abstract

“…Given that the prevalence of HCV is 0.4% in the general population , these values are 25 and 100 times higher in prisons than the general population. In France, the prevalence of HCV was estimated to be six times higher in the general prison population than in the general population .…”

Section: Discussionmentioning

confidence: 99%

Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio‐behavioural surveillance survey in 2015

Moradi

Gouya

Zavareh

et al. 2018

Tropical Med Int Health

View full text Add to dashboard Cite

Although vaccination is used to control HBV among prisoners, prevalence of HCV exposure is alarming in the prison population of Iran, especially among people who inject drugs. Eliminating viral hepatitis in Iran by 2030 requires a national commitment and rapid measures for targeting this high-risk group. Given the increased efficiency of HCV treatment in recent years, prisons provide an opportunity to access patients for treatment.

show abstract

“…In French Guiana, HIV prevalence among inmates was 3.9% in 2014 [5], which is around 4 times higher than the general population, and twice the prevalence reported in the French national correctional facility survey [6]. …”

Section: Introductionmentioning

confidence: 99%

High mortality among male HIV-infected patients after prison release: ART is not enough after incarceration with HIV

et al. 2017

View full text Add to dashboard Cite

ContextFrench Guiana is a South American French territory, where HIV prevalence consistently exceeds 1% in the adult population. In the only correctional facility, HIV prevalence fluctuates at around 4%.AimsAfter describing the population of HIV-positive inmates, we aimed to evaluate mortality after release from the correctional facility, and to identify its predictive factors.RationaleOutside North American settings, data on treatment outcome and vital status of HIV-positive former inmates are scarce. There were no data in French Guiana. Filling this gap represents a basis for potential improvements.MethodsAll HIV-infected adults released from an incarceration of 30 days or more, between 2007 and 2013, were enrolled in a retrospective cohort study. Mortality was described over time, one to seven years following release, using Kaplan-Meier estimates. Factors associated with mortality were identified through a non-parametric survival regression model.Results147 former inmates were included. The male to female ratio was 4.4. The median age was 37.3 years. The majority were migrants, 25.8% were homeless, 70.1% suffered from substance abuse, with 34.0% of crack-cocaine users. On admission, 78.1% had an early HIV-stage infection (CDC-stage A), with a median CD4 count of 397.5/mm3, 34.0% had one comorbidity, mainly hypertension. Upon release, 50.3% were on ART. Reasons for not being treated were not fulfilling the criteria for 74.6%, and refusing for 15.1%. Before release, 84.5% of the patients on ART had a viral load≤200cp/ml. After release, 8.2% of the cohort had died, with a crude incidence of 33.8/1000 person-years. All recorded deaths were males, with an incidence of 42.2/1000 person-years. Comparing with the age-specific mortality rates for males in French Guiana, the standardized mortality ratio was 14.8. In multivariate analysis, factors associated with death were age and CD4 count before release.ConclusionDespite access to ART while incarcerated, with good virological outcome, the post-release mortality was very high for males, almost 15 times what is observed in the general male population living in French Guiana, after age standardization. Access to ART in correctional facilities may be a necessary, but not sufficient condition to protect male inmates from death after release.

show abstract

Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy

Cited by 59 publications

References 33 publications

Incarceration of People Living with HIV/AIDS: Implications for Treatment-as-Prevention

Incarceration of People Living with HIV/AIDS: Implications for Treatment-as-Prevention

Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio‐behavioural surveillance survey in 2015

High mortality among male HIV-infected patients after prison release: ART is not enough after incarceration with HIV

Contact Info

Product

Resources

About